{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:38:02Z","timestamp":1779878282227,"version":"3.53.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The effect of remdesivir on COVID-19 mortality remains conflicting. Elderly individuals are at risk for poor COVID-19 outcomes. We aimed to assess the effect of remdesivir on COVID-19 mortality among elderly individuals, using real-world data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective multinational cohort of individuals aged \u226565 years, hospitalized with COVID-19 in six medical centres between January 2020 and May 2021. Associations with in-hospital mortality were evaluated using a multivariable logistic regression model with propensity score adjustment for remdesivir therapy and while implementing generalized estimating equations to control for centre effect. Sensitivity analysis was performed by stratification according to the degree of respiratory support.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 3010 individuals included, 2788 individuals required either oxygen supplementation or non-invasive\/invasive mechanical ventilation, 489 (16%) were treated with remdesivir, and 836 (28%) died. Median age was 77 (IQR 70\u201384) years and 42% were women. Remdesivir was the only therapeutic intervention associated with decreased mortality [adjusted OR (aOR) 0.49, 95% CI 0.37\u20130.66, P\u200a&amp;lt;\u200a0.001]. This protective effect was shown for individuals requiring oxygen support and non-invasive mechanical ventilation, while no association was found among individuals necessitating invasive mechanical ventilation.<\/jats:p>\n                  <jats:p>Risk factors for mortality included invasive ventilation (aOR 5.18, 95% CI 2.46\u201310.91, P\u200a&amp;lt;\u200a0.001), higher serum creatinine (aOR 1.25, 95% CI 1.09\u20131.43, P\u200a=\u200a0.001) and dyspnoea (aOR 1.40, 95% CI 1.07\u20131.84, P\u200a=\u200a0.015) on presentation, and other non-modifiable factors, such as comorbidities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among elderly individuals hospitalized with COVID-19, remdesivir carries survival benefit for those with moderate to severe disease. Its role among individuals with critical illness should be further assessed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkad118","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T14:18:35Z","timestamp":1682173115000},"page":"1505-1509","source":"Crossref","is-referenced-by-count":7,"title":["Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-418X","authenticated-orcid":false,"given":"Ili","family":"Margalit","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital , Petah-Tikva , Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Ramat Aviv , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Tiseo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-0377","authenticated-orcid":false,"given":"Marco","family":"Ripa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, San Raffaele Scientific Institute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanni","family":"Borghi","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, University of Modena and Reggio Emilia , Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefziba","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Medicine A, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Prendki","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Switzerland, and Faculty of Medicine, University of Geneva, Switzerland; Division of Infectious Diseases, Geneva University Hospitals , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Riccardi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Perego","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Istituto Auxologico Italiano, San Luca Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Grembiale","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Azienda Sanitaria Friuli Occidentale, Santa Maria degli Angeli Hospital , Pordenone , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, San Raffaele Scientific Institute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tinelli","sequence":"additional","affiliation":[{"name":"Division of Infectious and Tropical Diseases, Istituto Auxologico Italiano, IRCCS, San Luca Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, San Raffaele Scientific Institute , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia , Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-8796","authenticated-orcid":false,"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-9791","authenticated-orcid":false,"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tel Aviv University, Ramat Aviv , Tel Aviv , Israel"},{"name":"Infectious Diseases Unit, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"2023060100351860400_dkad118-B1","author":"NIH, COVID-19 Treatment Guidelines Panel"},{"key":"2023060100351860400_dkad118-B2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","article-title":"ESCMID COVID-19 living guidelines: drug treatment and clinical management","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2023060100351860400_dkad118-B3","author":"WHO, COVID-19 Management Guideline Development Group"},{"key":"2023060100351860400_dkad118-B4","doi-asserted-by":"crossref","first-page":"m2980","DOI":"10.1136\/bmj.m2980","article-title":"Drug treatments for covid-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"BMJ"},{"key":"2023060100351860400_dkad118-B5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cmi.2022.04.018","article-title":"Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2023060100351860400_dkad118-B6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/M21-4784","article-title":"Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians practice points","volume":"175","author":"Kaka","year":"2022","journal-title":"Ann Intern Med"},{"key":"2023060100351860400_dkad118-B7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jamda.2020.05.045","article-title":"The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects","volume":"21","author":"Bonanad","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"2023060100351860400_dkad118-B8","doi-asserted-by":"crossref","first-page":"e2114741","DOI":"10.1001\/jamanetworkopen.2021.14741","article-title":"Association of remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19","volume":"4","author":"Ohl","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023060100351860400_dkad118-B9","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.3390\/jcm11133769","article-title":"Remdesivir in very old patients (\u226580 years) hospitalized with COVID-19: real world data from the SEMI-COVID-19 registry","volume":"11","author":"Ramos-Rincon","year":"2022","journal-title":"J Clin Med"},{"key":"2023060100351860400_dkad118-B10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clinthera.2022.01.007","article-title":"Early use of remdesivir and risk of disease progression in hospitalized patients with mild to moderate COVID-19","volume":"44","author":"Falcone","year":"2022","journal-title":"Clin Ther"},{"key":"2023060100351860400_dkad118-B11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40261-022-01187-x","article-title":"Clinical characteristics and implications of bradycardia in COVID-19 patients treated with remdesivir: a single-center retrospective cohort study","volume":"42","author":"Schreiber","year":"2022","journal-title":"Clin Drug Investig"},{"key":"2023060100351860400_dkad118-B12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmi.2022.09.019","article-title":"Predictors of survival in elderly patients with COVID-19 admitted to the hospital: derivation and validation of the FLAMINCOV score","volume":"29","author":"Tiseo","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2023060100351860400_dkad118-B13","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01814-20","article-title":"New perspectives on antimicrobial agents: remdesivir treatment for COVID-19","volume":"65","author":"Aleissa","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060100351860400_dkad118-B14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12929-020-00703-5","article-title":"Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications","volume":"28","author":"Trougakos","year":"2021","journal-title":"J Biomed Sci"},{"key":"2023060100351860400_dkad118-B15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients","volume":"21","author":"Dessie","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2023060100351860400_dkad118-B16","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/STROKEAHA.121.036257","article-title":"Increased COVID-19 mortality in people with previous cerebrovascular disease: a population-based cohort study","volume":"53","author":"Lazcano","year":"2022","journal-title":"Stroke"},{"key":"2023060100351860400_dkad118-B17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/8755122520967634","article-title":"Remdesivir and coronavirus disease 2019 (COVID-19): essential questions and answers for pharmacists and pharmacy technicians","volume":"37","author":"Veronin","year":"2021","journal-title":"J Pharm Technol"},{"key":"2023060100351860400_dkad118-B18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/cts.13261","article-title":"Postmarketing pharmacovigilance: remdesivir and cardiovascular events","volume":"15","author":"Sullivan","year":"2022","journal-title":"Clin Transl Sci"},{"key":"2023060100351860400_dkad118-B19","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/6\/1505\/50488898\/dkad118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/6\/1505\/50488898\/dkad118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:39:04Z","timestamp":1685579944000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/78\/6\/1505\/7136599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,22]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkad118","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,4,22]]}}}